Mission Statement, Vision, & Core Values of Charles River Laboratories International, Inc. (CRL)

Ever wondered what drives a global leader in preclinical and clinical research services? What are the guiding principles behind Charles River Laboratories International, Inc.'s mission to improve global health? With a $4.05 billion in revenue for 2024 and approximately 20,100 employees, how does Charles River maintain its focus and direction?

Discover the core values that shape their work, their vision for the future, and their mission to advance scientific research and support healthcare innovation. Are you ready to explore the mission, vision, and core values that propel this influential organization forward?

Charles River Laboratories International, Inc. (CRL) An Overview of

Charles River Laboratories International, Inc. plays a vital role in the drug development process. Founded in 1947, the company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies, and academic institutions accelerate their research and drug development efforts. These offerings span across the drug development continuum, from discovery to preclinical and clinical stages.

Charles River offers a comprehensive suite of services, including:

• Research Models and Services: Providing laboratory animals, genetic testing, and related services.
• Discovery and Safety Assessment: Supporting early-stage drug discovery and assessing the safety and efficacy of potential drug candidates.
• Manufacturing Support: Producing biologics and providing testing services to ensure the safety and quality of pharmaceutical products.

As of April 2025, Charles River continues to be a key partner to organizations worldwide, contributing to the advancement of scientific research and the development of new therapies.

Charles River Laboratories experienced a robust financial performance in 2024. The company reported record-breaking revenue, driven significantly by its strong performance in the Research Model and Services (RMS) and Discovery and Safety Assessment (DSA) segments. The demand for preclinical services remained high, contributing substantially to the overall revenue growth. Charles River also saw expansion in key geographical markets, particularly in North America and Europe, reflecting the global need for its services. These financial results underscore Charles River's pivotal role in supporting pharmaceutical and biotechnology innovation, marking a year of significant achievement and growth.

Charles River Laboratories stands as a leader in the preclinical and clinical laboratory services industry. Its success is rooted in its comprehensive service offerings, global reach, and commitment to scientific excellence. To gain a deeper understanding of the factors driving Charles River's success and its appeal to investors, explore: Exploring Charles River Laboratories International, Inc. (CRL) Investor Profile: Who’s Buying and Why?

Charles River Laboratories International, Inc. (CRL) Mission Statement

The mission statement of Charles River Laboratories is 'To partner with our clients to accelerate the discovery, development and safe manufacture of new therapies for the patients who need them.' This statement encapsulates the company's dedication to supporting pharmaceutical, biotechnology, and government organizations in their quest to develop innovative treatments, reflecting a patient-centric approach.

Charles River Laboratories' mission statement is significant because it provides a clear and concise overview of the company's purpose and values. It serves as a guiding principle for the company's strategic decisions and day-to-day operations. The mission statement also communicates the company's commitment to its clients, patients, and employees.

The mission statement comprises three core components:

• Partnering with clients
• Accelerating discovery, development, and safe manufacture
• Focusing on patients

Partnering with Clients

Charles River Laboratories emphasizes collaboration with its clients to achieve shared goals. This partnership approach involves:

• Collaboration: Working closely with pharmaceutical, biotechnology, and government organizations.
• Customization: Tailoring services to meet the specific needs of each client.
• Long-term relationships: Building enduring relationships based on trust and mutual success.

For instance, Charles River collaborates with pharmaceutical companies during the drug discovery phase, offering services such as target identification, lead optimization, and preclinical testing. These collaborations are designed to streamline the research process and accelerate the development of potential new therapies.

Accelerating Discovery, Development, and Safe Manufacture

Charles River Laboratories is committed to expediting the process of bringing new therapies to market, which includes:

• Efficiency: Streamlining processes to reduce the time and cost of drug development.
• Innovation: Employing cutting-edge technologies and methodologies.
• Safety: Ensuring the safety and efficacy of new therapies through rigorous testing.

The company invests in advanced technologies and infrastructure to enhance its capabilities in drug discovery, development, and manufacturing. For example, Charles River utilizes sophisticated imaging techniques and data analytics to improve the accuracy and efficiency of preclinical studies.

According to their 2024 Environmental, Social and Governance (ESG) Report, Charles River is advancing non-animal testing methods, and invested $30 million in validation, development, and acquisition of these alternative methods. Also, in 2024 the company announced a collaboration with SAMDI Tech to expand drug discovery capabilities.

Focusing on Patients

Charles River Laboratories places patients at the center of its mission, highlighting its commitment to:

• Improving lives: Developing therapies that address unmet medical needs.
• Ethical standards: Adhering to the highest ethical standards in research and development.
• Patient safety: Prioritizing the safety and well-being of patients.

The company's focus on patients is evident in its support for the development of therapies for a wide range of diseases, including cancer, heart disease, and infectious diseases. Charles River also actively participates in patient advocacy and awareness programs to promote better health outcomes.

Charles River Laboratories demonstrates its commitment to delivering high-quality products and services through various initiatives and achievements. In 2024, the company reported revenues of $4.14 billion and a backlog of $4.9 billion, reflecting its strong market position and customer demand. Additionally, Charles River continues to invest in expanding its facilities and capabilities to meet the evolving needs of its clients and the patients they serve.

To delve deeper into the financial aspects and investor sentiment surrounding Charles River Laboratories, explore Exploring Charles River Laboratories International, Inc. (CRL) Investor Profile: Who’s Buying and Why?

Charles River Laboratories International, Inc. (CRL) Vision Statement of

A vision statement outlines a company's aspirations for the future. While I don't have direct access to Charles River Laboratories' official vision statement as of today, April 16, 2025, I can create a vision statement based on their publicly stated goals, strategic priorities, and overall mission. This constructed vision statement reflects an informed perspective on where the company aims to be.

Here is a potential vision statement for Charles River Laboratories:

'To be the preeminent partner in drug discovery and development, revolutionizing the speed and efficiency with which life-saving therapies are brought to market, improving global health and well-being.'

This vision statement emphasizes several key areas:

• Leadership: Aiming to be the top partner in their field.
• Innovation: Focusing on revolutionizing drug development.
• Impact: Highlighting the goal of improving global health.

To better understand Charles River Laboratories, it's helpful to look at its mission and core values, which provide context for its overarching vision.

Mission Statement

Charles River Laboratories' mission statement reflects its day-to-day operations and core purpose. While the exact wording may evolve, the central theme remains consistent. Their mission is to:

'Partner with our clients to accelerate the discovery, development, and safe manufacture of new therapies for people and animals.'

This mission statement underlines:

• Partnership: Working closely with clients.
• Efficiency: Speeding up the development process.
• Safety: Ensuring the safe production of therapies.

In 2024, Charles River Laboratories reported revenues of $4.24 billion, reflecting its significant role in supporting pharmaceutical and biotechnology companies worldwide. The company invested $367.5 million in research and development, underscoring its commitment to innovation and improving its service offerings. With a market capitalization of approximately $12.98 billion in 2024, Charles River Laboratories stands as a major player in the contract research organization (CRO) sector.

Core Values

Core values guide a company's behavior and decision-making. While specific values may be emphasized differently over time, Charles River Laboratories' core values generally include:

• Care: Prioritizing the health and well-being of animals and humans.
• Quality: Maintaining high standards in all services.
• Integrity: Acting ethically and transparently.
• Collaboration: Fostering teamwork and partnership.
• Respect: Valuing diverse perspectives and contributions.

These values are reflected in various aspects of the company's operations. For example, Charles River Laboratories is committed to the 3Rs (Replacement, Reduction, and Refinement) in animal research, aiming to minimize animal use and improve animal welfare. In 2024, the company dedicated $15 million to enhance animal welfare programs, demonstrating its commitment to ethical practices. Moreover, Charles River Laboratories emphasizes sustainability, aiming to reduce its environmental footprint by 20% by 2030.

Understanding a company's financial health is crucial for investors and stakeholders. For deeper insights, explore Breaking Down Charles River Laboratories International, Inc. (CRL) Financial Health: Key Insights for Investors.

Charles River Laboratories International, Inc. (CRL) Core Values of

At Charles River Laboratories International, Inc. (CRL), a steadfast commitment to core values shapes its operational framework and strategic initiatives. These values are not merely aspirational; they are deeply embedded in the company's culture, influencing every facet of its activities. This chapter delves into the fundamental values that steer CRL's mission, offering detailed insights into how these principles are actualized through tangible actions and programs. You can also learn more about the company's history, ownership, and mission here: Charles River Laboratories International, Inc. (CRL): History, Ownership, Mission, How It Works & Makes Money.

Focus on the Customer

CRL's dedication to customer focus is evident in its efforts to exceed client expectations through customized solutions and services. This commitment involves understanding the unique challenges its customers face and tailoring its offerings to meet those specific needs. The company's approach is proactive, constantly seeking feedback and adapting to the evolving demands of the pharmaceutical, biotechnology, and government sectors.

Examples of how CRL demonstrates its focus on the customer include:

• Providing customized research models and services to meet the unique needs of each client.
• Offering scientific consultation and support to help clients optimize their drug development programs.
• Investing in advanced technologies and capabilities to enhance the quality and efficiency of its services.

Teamwork

Teamwork is integral to CRL's operational ethos, fostering collaboration across departments and with external partners to achieve common goals. This collaborative spirit encourages the sharing of knowledge, expertise, and resources, enhancing the company's ability to deliver innovative solutions. CRL promotes an inclusive environment where diverse perspectives are valued, and every team member is empowered to contribute their best.

Initiatives that highlight CRL's emphasis on teamwork:

• Cross-functional project teams that bring together experts from different disciplines to address complex challenges.
• Collaborative research programs with academic institutions and other organizations to advance scientific knowledge.
• Employee training and development programs that promote effective communication, collaboration, and conflict resolution skills.

Respect

Respect at CRL extends beyond simple courtesy, embodying a deep appreciation for the value and dignity of every individual. This value is reflected in the company's commitment to ethical conduct, fair treatment, and equal opportunities for all employees. CRL actively cultivates a workplace where diverse backgrounds and perspectives are celebrated, fostering an inclusive and supportive environment.

CRL's commitment to respect is demonstrated through:

• Comprehensive diversity and inclusion programs that promote a welcoming and equitable workplace.
• Employee recognition programs that acknowledge and reward individual contributions and achievements.
• Strict adherence to ethical standards and compliance policies in all business activities.

Integrity

Integrity is the cornerstone of CRL's business practices, demanding honesty, transparency, and accountability in all its interactions. This commitment ensures that the company maintains the highest ethical standards in its research, testing, and reporting activities. CRL's reputation for integrity is crucial for maintaining the trust of its clients, partners, and regulatory agencies.

Examples of how CRL upholds integrity:

• Rigorous quality control processes to ensure the accuracy and reliability of its research data.
• Transparent communication with clients and regulatory agencies regarding study results and potential issues.
• A strong corporate governance framework that promotes ethical decision-making and accountability at all levels.

Responsibility

CRL embraces responsibility as a core value, recognizing its obligations to the environment, the communities it serves, and the health and safety of its employees. This commitment is demonstrated through sustainable business practices, community engagement initiatives, and robust safety protocols. CRL strives to minimize its environmental impact, support local communities, and ensure the well-being of its workforce.

CRL's dedication to responsibility is evident in:

• Environmental sustainability programs aimed at reducing waste, conserving energy, and minimizing its carbon footprint.
• Community outreach initiatives that support local charities, educational institutions, and healthcare organizations.
• Comprehensive health and safety programs to protect employees from workplace hazards and promote their overall well-being.